Gwenesta B. Melton, MD, wears many hats as a rheumatologist, teacher and champion for advocacy and collaboration. She has been involved with the ASC for more than a decade.
Congressional Action Partially Addresses Medicare Cuts
The newest funding package reduces the latest cut to Medicare reimbursement from 3.4% to 1.68%. Although rheumatologists are faring better under Medicare in 2024, broader reforms remain the ACR’s highest priority regarding Medicare payments to physicians.
Updated Coding Guidance for 2024 Remote Physiologic Monitoring & Therapeutic Monitoring
The Centers for Medicare & Medicaid Services updated recent regulations to clarify some points about remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) services for key areas.
RheumPAC’s Role in the ACR’s Advocacy Efforts
In an election year, it is critical that the ACR’s non-partisan political action committee be well positioned to support our congressional champions. Learn more about RheumPAC and its role in the ACR’s advocacy efforts.
Updates from the ACR Insurance Subcommittee
The Insurance Subcommittee is working to address coverage and reimbursement challenges facing rheumatology practices, including issues related to biosimilar use, in-office treatments and the new G2211 code.
Sharad Lakhanpal, MBBS, MD, Named an APLAR Master
In early December, Sharad Lakhanpal, MBBS, MD, a rheumatologist at Rheumatology Associates in Dallas and past president of the ACR, traveled to Chiang Mai, Thailand, for the 2023 Congress of the Asia Pacific League of Associations for Rheumatology (APLAR). There he was named an APLAR Master. The award is presented to someone not from APLAR,…
When to Check Drug Levels & Why
Checking blood levels of commonly used disease-modifying anti-rheumatic drugs (DMARDs) has gained widespread attention in the rheumatology community, even resulting in a recent guidance document from EULAR for biologics.1 Although a highly useful tool, drug level measurement in rheumatology is not without challenges; many of our drugs violate the basic principles of pharmacology that we…
ACR Image Competition 2023 Results, Part 4
For the 2023 Image Competition, the ACR sought images representing a diverse range of patients with idiopathic inflammatory myopathies (IIMs) or IIM mimics. Unilateral Heliotrope Rash in Anti-MDA-5 Antibody Dermatomyositis These images depict a 36-year-old patient with arthralgias, dyspnea and a unilateral heliotrope rash (image A). A unilateral heliotrope rash is a distinctive, but rare,…
‘Where Are You From?’ & Other Microaggressions
“I’m actually from Iowa. Where do you hail from?” I replied, in the friendliest tone I could muster. Many readers may already know the context, but I’ll rewind a few moments to clear up any ambiguity. I was in clinic and talking with a kind lady with joint pain. While I was in the middle…
SMILE, an Online Lupus Tool, Can Aid Shared Decision Making
Patients with systemic lupus erythematosus (SLE) often face many concerns, fears and uncertainties that render “treatment decision making very difficult,” says Jasvinder Singh, MD, MPH, professor of medicine and epidemiology at the University of Alabama at Birmingham. Often these patients, who tend to be women from minority groups, “do not have access to easily understandable…
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 814
- Next Page »